JohnGreerMD

Hematology • Nashville, TN

Hematologic Oncology

Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Greer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Greer's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Fax+1 615-936-0605

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1984
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
Virginia Commonwealth University Health SystemResidency, Pediatrics, 1979 - 1981
Tulane UniversityResidency, Internal Medicine, 1976 - 1979
Vanderbilt University School of MedicineClass of 1976

Certifications & Licensure

TN State Medical License 1981 - 2022
LA State Medical License 1976 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Completed
Phase 3

Publications & Presentations

PubMed

Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Tran...
Dilan A Patel, Karina A. Mendoza, Heidi Chen, Brian G. Engelhardt, Bipin N. Savani
Journal of Hematology. 2021-02-06
2 citations
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis
Xuanyi Li, Elizabeth Sigworth, Adrianne H. Wu, Jess Behrens, Shervin A. Etemad
Scientific Reports. 2020-10-16
23 citations
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
Frederick Lansigan, Steven M. Horwitz, Lauren C. Pinter-Brown, Steven T. Rosen, Barbara Pro
Acta Haematologica. 2020-01-01

Press Mentions

Magnet Designation Leader Downs Set to RetireAugust 25th, 2021
Opinion Imagining the World After COVID-19June 22nd, 2020
Vanderbilt Poll: A Majority of Nashvillians Approve of Local LeadersApril 16th, 2021